Subsequent Events

12 Months Ended

Jun. 30, 2018

Subsequent Events [Abstract]

Subsequent Events

11. SUBSEQUENT EVENTS

The Company evaluates subsequent events through the time of our filing on the date we issue our financial statements, which was on October 15, 2018. The following are matters which occurred subsequent to June 30, 2018:

● In September 2018, we received a distribution from our real estate limited partnership investment of approximately $370,000;

● In September 2018, RedHawk Medical Products, LLC, a wholly-owned subsidiary of the Company, acquired the world-wide exclusive manufacturing and distribution rights to certain intellectual properties which the Company believes will significantly expand the current market capabilities of its SANDD mini needle destruction unit;

● In August 2018, we increased our authorized shares from 1,000,000,000 to 2,000,000,000.

● In August 2018, we received notice from holders of the Variable Rate Convertible Notes of their intent to convert such notes into common stock. The conversion process is still in progress as of the filing date.